SIRT3 and glioblastoma: By affecting the abundance of metabolites in the TCA cycle, such as α-KG and succinate, SIRT3 regulates demethylase activity, the histone methylation level, and SLC7A11 expression in GBM cells, and this needs to be verified in future work.